12:53:22 EDT Fri 26 Apr 2024
Enter Symbol
or Name
USA
CA



Shell Summary for July 7, 2016

2016-07-07 20:35 ET - Market Summary

This item is part of Stockwatch's value added news feed and is only available to Stockwatch subscribers.

Here is a sample of this item:

by Stockwatch Business Reporter

The TSX Venture Exchange fell 9.86 points to 747.79 Thursday. Roger Dent's halted capital pool shell, Quinsam Opportunities I Inc. (QOP), plans to acquire VitalHub Corp., a medical app developer in Toronto, for the shell's qualifying transaction. Quinsam Opportunities, which has nine million shares issued, will issue 13,400,016 shares to VitalHub's shareholders.

VitalHub was formed in May, 2010. It has created an app called VitalHub Chart, which allows health care providers to access patient information on a cellphone or tablet. The information could include a patient's vital signs, lab results and medication history. First, a hospital must install a VitalHub server, after which its employees may use the VitalHub Chart app to access patient data. The app is available for free on the Apple App Store, the Microsoft Store and Google Play.

VitalHub Corp.'s controlling shareholders are Dan Matlow and Brian Goffenberg. Mr. Matlow was the founder of Medworxx Solutions Inc., a TSX-V-listed health care information technology company that is now a part of private U.S. software developer Aptean Inc. Medworxx's main product was a patient flow management program for hospitals. Medworxx traded from December, 2007, to October, 2015, peaking at 30 cents in February, 2008. Before founding Medworxx, Mr. Matlow was a vice-president of sales in the health care division of Open Text Corp. (OTC: $75.77), a very successful enterprise software company. On closing of Quinsam's QT, Mr. Matlow will be the president and a director of the resulting issuer.

The remainder is available to Stockwatch subscribers.
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

© 2024 Canjex Publishing Ltd. All rights reserved.


Reader Comments - Comments are open to paying subscribers of Stockwatch and unmoderated, although libelous remarks, obscene language and impersonations may be deleted. Opinions expressed do not necessarily reflect the views of Stockwatch.
For information regarding Canadian libel law, please view the University of Ottawa's FAQ regarding Defamation and SLAPPs.


Comments for this item are closed